Epigenetic biomarkers
Epify develops epigenetic biomarkers which control gene activity and are implicated in a wide range of cancers, driving and influencing the course of the disease. Using these biomarkers, Epify aims to drive earlier detection and more accurate diagnosis, facilitating personalized oncology and a better prognosis for cancer patients.

We were asked to create a brand for this newly founded company. We created a new logo, using it as inspiration to create a comprehensive look and feel across their communications. We also provided them with a new website created from our own design and copy. After the website launch, we provided social media support, as well as creating and distributing a press release.

Custom logo and associated brand identity

Custom-designed, scientific icons

Updated corporate presentation

For more information
Next Project
Breaking limits in bioanalysis